Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000022352 | SCV000791803 | pathogenic | Renal carnitine transport defect | 2017-05-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000022352 | SCV001592146 | pathogenic | Renal carnitine transport defect | 2024-01-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg282Aspfs*14) in the SLC22A5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC22A5 are known to be pathogenic (PMID: 9916797). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with primary carnitine deficiency (PMID: 12210323). This variant is also known as g.17081delC. ClinVar contains an entry for this variant (Variation ID: 25399). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000022352 | SCV002055815 | pathogenic | Renal carnitine transport defect | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000022352 | SCV002813868 | pathogenic | Renal carnitine transport defect | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000022352 | SCV004203569 | pathogenic | Renal carnitine transport defect | 2023-05-03 | criteria provided, single submitter | clinical testing |